Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy.
Mies
S
S
Liver Unit, Faculdade de Medicina da Universidade de São Paulo, Brazil.
Massarollo
P C
PC
Figueira
E R
ER
Leitão
R M
RM
Raia
S
S
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002648:Child; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004110:Diltiazem / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use*; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies
D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D016572:Cyclosporine; D004110:Diltiazem